ImmunityBio (IBRX) Executes $40M Equity Financing with Institutional Investors

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/17/2026

1. VRNS
2. JBHT
3. CRWV
4. TSLA
5. GPRK
6. SCHW
7. TRV
8. TFC
9. NVDA
10. POLYCAB:IN

Go back to ImmunityBio (IBRX) Executes $40M Equity Financing with Institutional Investors

ImmunityBio Announces Execution of $40 Million Equity Financing with Institutional Investors

July 20, 2023 8:32 PM EDT

CULVER CITY, Calif.--(BUSINESS WIRE)-- ImmunityBio, Inc. (NASDAQ: IBRX), a clinical-stage immunotherapy company, today announced that it has executed financing to provide further working capital and support its ongoing business operations. The Company entered into a securities purchase agreement for a registered direct offering with multiple institutional investors, providing for the issuance of common stock of... More